| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 89.8876 | 74 |
| GSM780708 | Untreated after 4 days (C2_1) | 158.063 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 77.2679 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 84.2006 | 73 |
| GSM780720 | Untreated after 4 days (C2_2) | 142.63 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 97.4178 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 113.628 | 77 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 90.092 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 103.075 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 103.401 | 76 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 96.5846 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 102.886 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 92.6542 | 74 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 101.239 | 75 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 95.862 | 75 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 79.1914 | 71 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 99.6693 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 80.0606 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 134.946 | 79 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 134.946 | 79 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 131.456 | 79 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 114.684 | 77 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 134.048 | 79 |